<DOC>
	<DOC>NCT01525095</DOC>
	<brief_summary>The purpose of this study is to assure the uniform collection, handling, storage and transport of patient whole blood specimens and associated information to support validation of the T2 Candida Assay.</brief_summary>
	<brief_title>Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)</brief_title>
	<detailed_description />
	<mesh_term>Candidemia</mesh_term>
	<criteria>1. Subject or subject's authorized representative must be able to understand, read and sign the study specific informed consent form after the nature of the study has been fully explained to them. 2. For Group A, Males and females 18 95 years of age. Subject is confirmed to have fungemia as evidenced by a positive diagnostic blood culture and subsequent species identification. 3. For Group B, Males and females 18 95 years of age. Subject is hospitalized with a medical problem other than fungemia, or is being treated as an outpatient for some noninfectionrelated condition, and Subject is confirmed to not have fungemia as evidenced by diagnostic blood culture and subsequent species identification. 1. Use of any novel (i.e. not commercially available) drug compound within 30 days prior to the collection of T2 blood specimens. 2. Subject has other comorbid condition(s) that, in the opinion of the Investigator, could limit the subject's ability to participate in the study or impact the scientific integrity of the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Candida</keyword>
	<keyword>Diagnostic Assay</keyword>
	<keyword>Blood culture</keyword>
	<keyword>Sepsis</keyword>
	<keyword>T2 Magnetic Relaxation</keyword>
</DOC>